MESOTHELIOMA CANCER CENTERS
Mesothelioma cancer centers offer the care patients diagnosed with mesothelioma need. Finding a center staffed with specialists who understand how to treat mesothelioma is the most important decision a patient can make.
Mesothelioma cancer centers have experienced staff who can provide the best treatment for patients diagnosed with mesothelioma. Choosing the right cancer center is the most important step a patient can take towards improving their prognosis.
Eastern U.S. Treatment Centers
Brigham and Women’s Hospital
75 Francis Street, Boston, MA 02115
The Brigham and Women’s Hospital houses the world-renowned International Mesothelioma Program (IMP), which is a joint program made up of departments from the Dana-Farber Cancer Institute and the Harvard Public School of Health. It was founded by Dr. David Sugarbaker, who developed the extrapleural pneumonectomy (EPP) surgery.
Memorial Sloan-Kettering Cancer Center
1275 York Avenue, New York, NY 10021
The Memorial Sloan-Kettering Cancer Center is one of the oldest medical centers in the United States and is well-known for its cutting-edge cancer treatments. Its specialists have performed more surgeries than any hospital in the nation and are leaders in new, emerging treatments, like immunotherapy. Dr. Valerie Rusch manages the mesothelioma department, where clinical trials and advanced research are conducted.
H. Lee Moffitt Cancer Center & Research Institute
12902 Magnolia Drive, Tampa, FL 33612
The H. Lee Moffitt Center is the most notable cancer treatment center in Florida. It houses the Mesothelioma Research and Treatment Center, a program within the Department of Thoracic Oncology. Dr. Scott Antonia heads the program, which is focused on multimodal treatment, clinical research, and patient care.
Georgia Regents University (GRU) Cancer Center
1411 Laney Walker Blvd, Augusta, GA 30912
The GRU Cancer Center’s mission is to fight cancer locally and globally with state-of-the-art treatment facilities. Their program focuses on clinical care and world class research, approaching cancer treatment with an effective, patient-centered model. GRU is currently hosting a number of clinical trials investigating the use of new, emerging cancer treatments. One of these trials is testing the effectiveness of tremelimumab, a form of immunotherapy, on patients with unresectable pleural and peritoneal mesothelioma.
Midwestern U.S. Treatment Centers
Ohio State University Comprehensive Cancer Center
300 West 10th Avenue, Columbus, OH 43210
The OSU Cancer Center is one of the leading research hospitals in the United States and has been designated as a Comprehensive Cancer Institute by the National Cancer Institute. Their staff is famous for creating individualized treatments that fit each patient’s cancer diagnosis. Notable staff includes Dr. Gregory Otterson, who specializes in treating many thoracic cancers, including mesothelioma.
University of Michigan Comprehensive Cancer Center
1500 East Medical Center Drive, Ann Arbor, MI 48109
The Thoracic Oncology Program at the University of Michigan treats multiple forms of lung cancer, including pleural mesothelioma. Its staff focuses on multimodal courses of treatment, and are experts in surgery, chemotherapy, and radiation therapy. The Thoracic Oncology Program also participates in clinical trials. These trials are often aimed at developing new chemotherapy and radiation therapy treatments. The U-M Cancer Center is also a part of the National Comprehensive Cancer Network.
Western U.S. Treatment Centers
University of Colorado Cancer Center
1665 Aurora Ct, Aurora, CO 80045
The UC Cancer Center’s Lung, Head and Neck Cancer Program, co-headed by Dr. York Miller and Dr. Xiao-Jing Wang, focuses on translational medicine. The goal of translational medicine is to develop research discoveries into workable treatments that can make a difference in a patient’s prognosis. Research interests of its specialists include the use of biomarkers in early cancer detection.
University of California Los Angeles Medical Center
10780 Santa Monica Blvd. , Los Angeles, CA 90024
The UCLA Medical Center is home to the Comprehensive Mesothelioma Program. It was founded in 1997 by Dr. Robert Cameron, who pioneered the pleurectomy with decortication (P/D) procedure. One of the program’s areas of expertise is the use of chemotherapy to treat the rare sarcomatoid mesothelioma cell type.
Choosing the Right Center
Mesothelioma accounts for nearly 0.3 percent of all cancer diagnoses. As a result, regular doctors do not see this rare disease as often as specialists. Few hospitals have access to facilities that can provide adequate treatment for mesothelioma. Even fewer are connected to clinical trials offering cutting-edge treatments. The right cancer center has the experienced staff and facilities necessary to provide the best treatment.
Each stage and type of mesothelioma is unique and requires specific treatment. A specialist should have the experience to treat a patient based on the stage and location of their cancer. The right cancer center will also have access to a network of experienced surgeons. Surgery is the most successful treatment option used to improve a mesothelioma patient’s prognosis. Access to qualified surgeons offers patients a better chance for an improved prognosis.
Specialists Tailor Treatments
Because there are so many factors that contribute to its development, mesothelioma affects each patient in a different way. The most effective treatment for mesothelioma is tailored to each patient’s individual diagnosis. Only an experienced team of specialists can offer the specialized treatment mesothelioma requires.
Specialized, Multidisciplinary Treatment
The most effective mesothelioma treatment involves a combination of surgery, chemotherapy and radiation therapy. This is known as a multimodal approach. A good treatment center employs specialists in different areas of expertise. These specialists can work as a team to provide the most effective course of treatment for a patient diagnosed with any stage of mesothelioma. Having access to a variety of specialists in one place helps patients avoid traveling to different centers.
Access to Clinical Trials and Emerging Treatments
Clinical trials offer cutting-edge treatments to patients diagnosed with any stage of mesothelioma. Early-stage patients can improve their prognosis with emerging treatments that attack mesothelioma aggressively. Clinical trials give advanced-stage patients access to experimental treatments with curative potential. A good mesothelioma cancer center has access to clinical trials that can make a difference in a patient’s life.